Whitehawk Therapeutics, Inc.
Current- Director 2021 to present
Executive record
Alpha ID: alpha:person:emma-reeveVersion: public-0As of: 2026-10-03
Connect capital, control, accountability, and evidence.
Ms. Reeve served as Senior Vice President and Chief Financial Officer of Constellation Pharmaceuticals, Inc. from October 2017 until its acquisition in July 2021. She previously served as Corporate Controller of Parexel International and held finance roles at Novartis, Merck Research Laboratories, and Bristol Myers Squibb. She is an associate of the Institute of Chartered Accountants in England & Wales.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageNo published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAlpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
sec filing · Source published: Apr 28, 2025 · Retrieved: May 16, 2026
sec proxy · Source published: Apr 28, 2025 · Retrieved: Apr 28, 2026
public source · Source published: Date unavailable · Retrieved: Date unavailable
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03